Clinical Trial Update: Hospital Based Incidence of Group A Streptococcal Disease in Fiji

View source ↗

Summary

A completed clinical trial sponsored by NIAID examined the hospital-based incidence of Group A Streptococcal disease in Fiji.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Group Streptococcal Infection
• Streptococcal Infections

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Streptococcus Group A | Status: COMPLETED